- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Dr. Salomé Cisnal de Ugarte
News 51 results
Recognition
December 4, 2025
King & Spalding Again Recognized on Global Competition Review’s GCR 100 List
In the News · Source: Global Legal Chronicle
June 26, 2025
K&S represents Aditya Birla Group on its $125M acquisition of AluChem
Cases & Deals
June 24, 2025
King & Spalding Is Representing ABG in Its $125 Million Acquisition of AluChem
In the News · Source: The Oath, Legalcommunity MENA and Global Legal Chronicle
June 12, 2025
K&S represents Dow on the sale and purchase agreement for the sale of its 50% interest in DowAksa
Events 11 results
Speaking Engagement
June 18, 2025
Salomé Cisnal de Ugarte to Speak at European University Institute (EUI) Seminar
Speaking Engagement
March 20, 2025
Salome Cisnal de Ugarte to Speak at Brussels’ Competition Law Conference
Speaking Engagement
January 29, 2025
Dr. Salomé Cisnal de Ugarte and Olivier Antoine to Speak at GCR’s Law Leaders Global Conference in Miami
Speaking Engagement
January 21, 2025
Dr. Salomé Cisnal de Ugarte to Speak at "GCR Live: Law Leaders Global 2025” Miami Conference
Insights 15 results
Thought Leadership
September 18, 2025
Brussels Antitrust Practice Publishes Study on behalf of CCIA Europe Examining EU Digital Markets Act Procedures, Proposes Reforms
Thought Leadership
September 15, 2025
Dr. Salomé Cisnal de Ugarte Re-appointed as Non-Governmental Advisor (NGA) to the EU at the International Competition Network (ICN)
Client Alert
September 4, 2025
Data Sharing in a Connected World: Does the EU Data Act Call for New Business Models?
Client Alert
May 20, 2025
UAE Implements Sweeping Competition Law Reforms with Mandatory Pre-Merger Notifications